Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-11

FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)

View source ↗

Summary

FDA approved a supplemental application for Fentanyl Transdermal filed by SpecGx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fentanyl transdermal (fentanyl transdermal system)

Snippet

SUPPL AP for FENTANYL TRANSDERMAL (FENTANYL TRANSDERMAL)